APA (7th ed.) Citation

GA, K., SCM, N., MJM, R., JH, v. d. L., CEM, H., & AM, B. (2019). Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I. Journal of inherited metabolic disease, 42(5), 762. https://doi.org/10.1002/jimd.12103

Chicago Style (17th ed.) Citation

GA, Kuiper, Nijmeijer SCM, Roelofs MJM, van der Lee JH, Hollak CEM, and Bosch AM. "Limited Data to Evaluate Real-world Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I." Journal of Inherited Metabolic Disease 42, no. 5 (2019): 762. https://doi.org/10.1002/jimd.12103.

MLA (9th ed.) Citation

GA, Kuiper, et al. "Limited Data to Evaluate Real-world Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I." Journal of Inherited Metabolic Disease, vol. 42, no. 5, 2019, p. 762, https://doi.org/10.1002/jimd.12103.